<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043921</article-id><article-id pub-id-type="pmc">6089131</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0184</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Survival and Risk Factors Among Dialytic Acute Kidney Injury Patients
After Cardiovascular Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Andrea B. V.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>RN, MSc</role></contrib><contrib contrib-type="author"><name><surname>Cavalcante</surname><given-names>Agueda Maria Ruiz Zimmer</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>RN, PhD</role></contrib><contrib contrib-type="author"><name><surname>Taniguchi</surname><given-names>Fabio P.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Instituto Dante Pazzanese de Cardiologia, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff2">
<label>2</label>IAMSPE Post Graduate Health Sciences Program, S&#x000e3;o Paulo, SP,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Andrea Braz Vendramini e Silva. Av. Dr.
Dante Pazzanese, 500 - Vila Mariana - S&#x000e3;o Paulo, SP, Brazil, Zip code:
04012-409. E-mail: <email>andreabvsilva@uol.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>277</fpage><lpage>285</lpage><history><date date-type="received"><day>25</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Acute kidney injury (AKI) is a frequent postoperative complication after
cardiovascular surgery. It has been described as a predictor of decreased
survival rates, but how dialysis decreases survival when initiated on the
postoperative period has yet to be determined. To analyze the survival of
patients who presented postoperative AKI requiring dialysis up to 30 days
after cardiovascular surgery and its risk factors is the aim of this study.
</p></sec><sec><title>Methods</title><p>Of the 5,189 cardiovascular surgeries performed in a 4-year period, 157
patients developed AKI requiring dialysis in the postoperative period. The
Kaplan-Meier survival curve and log-rank test were used in the statistical
analysis to compare the curves of categorical variables.
<italic>P</italic>-value&#x0003c; 0.05 was considered significant.</p></sec><sec><title>Results</title><p>Patient average survival was 546 days and mortality was 70.7%. The need for
dialysis on the postoperative period decreased late survival. Risk factors
for decreased survival included age (<italic>P</italic>&#x0003c;0.001) and
postoperative complications (<italic>P</italic>&#x0003c;0.0003).</p></sec><sec><title>Conclusion</title><p>The average survival was approximately one year among dialytic patients. Age
and postoperative complications were risk factors that determined decreased
survival.</p></sec></abstract><kwd-group><kwd>Renal Insufficiency</kwd><kwd>Survival Analysis</kwd><kwd>Cardiovascular Surgical Procedures</kwd><kwd>Renal Dialysis.</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute kidney injury</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
graft</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EGFR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Estimated glomerular
filtration rate</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EuroSCORE II</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European System for
Cardiac Operative Risk Evaluation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Acute kidney injury (AKI) is a disease of complex etiology, not fully understood,
that often takes place in the postoperative period of cardiovascular
surgery<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>. The incidence of postoperative AKI in
cardiovascular surgery remains high, approximately 20% of such surgical patients are
affected<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>,</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>.</p><p>In addition to being associated with postoperative complications, longer
hospitalizations, risk of infection and greater costs to the health system, AKI is
an independent predictor of intra-hospital mortality; since it increases mortality
by up to eight times, consequently decreasing the survival of
patients<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>,</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>.</p><p>Among those undergoing cardiovascular surgery, 1% to 5% may require renal replacement
therapy<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. Clinical variables influence the occurrence of
postoperative AKI, among other complications, and decreased survival
rates<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>,</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. Long-term survival among patients who underwent
cardiovascular surgery and acquired postoperative AKI requiring dialysis should be
evaluated in a diversified context, since it may confirm information regarding
length of survival and its associated risk factors. The aim of this study is to
analyze the risk factors in patients who acquired postoperative AKI requiring
dialysis after cardiovascular surgery and analyze its survival rates.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This retrospective study was conducted in a large public Brazilian hospital
specialized in cardiology. Consecutive patients referred to cardiovascular surgery
in a 4-year period were analyzed. Patients older than 18 years old, who underwent
cardiovascular surgery and presented AKI requiring dialysis up to 30 days in the
postoperative period, were eligible. Those who underwent congenital surgeries and
cardiac transplantation were excluded.</p><p>Data concerning clinical characteristics were analyzed and assigned into three
different groups. Preoperative variables were: sex, age, body mass index (BMI),
ethnicity, EuroSCORE (European System for Cardiac Operative Risk Evaluation) II,
estimated glomerular filtration rate (EGFR) and comorbidities. Intraoperative
variables were: type of surgery, cardiopulmonary bypass (CPB) time, use of
vasoactive drugs and the use of an intra-aortic balloon pump. Postoperative
variables included: length of mechanical ventilation, the use of vasoactive drugs,
red blood cells transfusions, clinical complications, length of stay in the
intensive care unit (ICU) and death.</p><p>Each patient's BMI was classified according to the guidelines established by the
World Health Organization and were used to assess nutritional
status<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>. The official website of the EuroSCORE II was used
to calculate the patients' score (<ext-link ext-link-type="uri" xlink:href="www.euroscore.org">www.euroscore.org</ext-link>). The
Cockcroft-Gault formula was used to estimate the glomerular filtration rate (acute
kidney injury stage 1 - increase in serum creatinine of &#x02265; 0.3 mg/dL or an
increase of 50 - 200% from baseline; stage 2 - increase in serum creatinine of 200 -
300%; and stage 3 - increase in serum creatinine of &#x0003e; 300% or serum creatinine
level &#x0003e; 4 mg/dL). The last laboratory result concerning the preoperative serum
creatinine levels was used and patients were classified according to the
classification established by the National Kidney Foundation
(2005)<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>. Survival was verified by consulting their
ambulatory follow-up records. When necessary, phone calls were performed.</p><p>IBM-SPSS (Statistical Package for the Social Sciences) version 19.0 (SPSS Institute,
Chicago, Illinois, USA) was used for the statistical analysis. Fisher's exact test
was used to compare the categorical variables. The survival of patients was
estimated and graphically represented using the Kaplan-Meier curves. The log-rank
test was used to compare survival curves. Pairwise comparison was performed when
there were more than two groups with Bonferroni correction. Variables that were
statistically significant (<italic>P</italic>&#x0003c;0.1) were submitted to multiple
analyses according to the Cox's proportional hazards model. Subsequently, the
StepWise Backward method was performed to obtain the final model. The variables that
presented <italic>P</italic>&#x0003c;0.05 on the latter were considered significant.</p><p>This study was approved by the Institutional Review Board at the hospital where the
data were collected (protocol No. 4205/12).</p></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 5,189 cardiovascular surgeries were conducted on adult patients on the
period of the study and 157 patients were identified in accordance with the
eligibility criteria. The patients' characteristics are presented in <xref rid="t1" ref-type="table">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical characterization and pre, intra and postoperative variables of
patients who presented postoperative acute kidney injury after
cardiovascular surgery and required dialysis. S&#x000e3;o Paulo, Brazil
2014.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">&#x000a0;</th><th align="left" rowspan="1" colspan="1">Characteristics of patients</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Mean/SD</th><th align="center" rowspan="1" colspan="1">Min/Max</th></tr></thead><tbody><tr><td align="left" rowspan="30" colspan="1">Preoperative variables</td><td align="left" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">Older than 60 years of age</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">54.8</td><td align="center" rowspan="2" colspan="1">&#x000a0;</td><td align="center" rowspan="2" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Younger than 60 years of age</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">45.2</td></tr><tr><td align="left" rowspan="6" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">Below normal (&#x0003c;18.5)</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="6" colspan="1">&#x000a0;</td><td align="center" rowspan="6" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal (18.5-24.9)</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">32.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Overweight (25.0-29.9)</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">32.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese class I (30.0-34.9)</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">20.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese class II (35.0-39.9)</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese class III (&#x02265; 40.0)</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2.7</td></tr><tr><td align="left" rowspan="4" colspan="1">Ethnicity</td><td align="left" rowspan="1" colspan="1">Caucasian</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">78.34</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Mixed</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">11.46</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Afro-descendent</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">8.28</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Asian</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1.91</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="10" colspan="1">Comorbidities</td><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior cardiovascular surgery</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic atrial fibrillation</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute myocardial infarction</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease </td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral vascular disease</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">EuroSCORE II</td><td align="center" colspan="2" rowspan="1">Median: 3.8% <break/>Mean:
6.62%<break/>SD: 7.97%</td><td align="center" rowspan="1" colspan="1">Quartile range<break/>2.08% - 7.37%</td><td align="center" rowspan="1" colspan="1">Min: 0.75%<break/>&#x000a0;Max: 52.51%</td></tr><tr><td align="left" rowspan="5" colspan="1">Renal Disease Classification</td><td align="left" rowspan="1" colspan="1">GFR I - Normal</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR II - Mild</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR III - Moderate</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR IV - Severe</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR V - Renal failure</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="8" colspan="1">Intraoperative variables</td><td align="left" rowspan="4" colspan="1">Type of Surgery</td><td align="left" rowspan="1" colspan="1">VR</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">49.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial revascularization</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">35.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Combined</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Thoracic aortic aneurysm repair</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="4" colspan="1">CPB time</td><td align="left" rowspan="1" colspan="1">&#x0003c;120 min</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">52.2</td><td align="center" rowspan="2" colspan="1">Mean: 121.45<break/>SD: 58.13</td><td align="center" rowspan="2" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02265;120 min</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">47.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Vasoactive drugs</td><td align="center" rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">86.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Intra-aortic balloon</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="17" colspan="1">&#x000a0;</td><td align="left" rowspan="12" colspan="1">Complications</td><td align="left" rowspan="1" colspan="1">Infections</td><td align="center" rowspan="1" colspan="1">113</td><td align="center" rowspan="1" colspan="1">72.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">45.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Bronchopneumonia</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">43.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiorespiratory arrest</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">21.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgical wound infection</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">19.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological </td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">11.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Low cardiac output</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Reoperation (hemostasis review)</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">10.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastrointestinal (upper GI bleed)</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">10.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">21.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Transfusion of packed red blood cells</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">52.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Vasoactive drugs</td><td align="center" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">96.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="5" colspan="1">Length of <break/>ICU stay (days)</td><td align="left" rowspan="1" colspan="1">1-3</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">23.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">4-10</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">24.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">11-30</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;30</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">19.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Time of mechanical ventilation (days)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0; Mean: 8.3<break/>SD: 15.2</td><td align="center" rowspan="1" colspan="1">Min:0<break/>Max: 121.0</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AMI=acute myocardial infarction; BMI=body mass index; CPB=cardiopulmonary
bypass; GFR=glomerular filtration rate; SD=standard deviation;
Min=minimum; Max=Maximum; VR=valve replacement</p></fn></table-wrap-foot></table-wrap><p>
<xref rid="t1" ref-type="table">Table 1</xref> shows a predominance of male patients
(59%), aged over 60 years (54.8%), Caucasians (78.34%), and overweight (mean BMI of
27.81 kg/m<sup>2</sup>). Comorbidities included: hypertension (85%), dyslipidemia
(62%), diabetes mellitus (40%), smoking (30%), previous cardiac surgery (27%). The
mean obtained for the EuroSCORE II was 6.62%.</p><p>In regard to the classification of kidney disease in the preoperative, 33% presented
GFR III (moderate), 29% GFR II (mild) and 22% GFR V (renal failure). In regard to
the type of surgery, valve surgeries (49.7%) predominated, followed by myocardial
revascularization (35.7%). The average duration of extracorporeal circulation was
121.45 minutes.</p><p>Complications identified in the postoperative period were: infections (72%), atrial
fibrillation (45.2%), cardiorespiratory arrest (21%), and other less frequent
complications (21.7%) that included acute myocardial infarction (AMI), pleural
effusion, cardiac arrhythmias, acute arterial occlusion, mesenteric ischemia and
liver failure. Survival was estimated at five different points in time over the
follow-up period, considering the variables in the pre, intra and postoperative
groups, shown in <xref rid="t2" ref-type="table">Table 2</xref>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Association between the pre, intra and postoperative and survival at
different points in time with survival and CI 95% (lower lim - upper lim).
S&#x000e3;o Paulo, Brazil 2014.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="left" rowspan="1" colspan="1">Time since surgery</th><th align="center" rowspan="1" colspan="1">30 days</th><th align="center" rowspan="1" colspan="1">180 days</th><th align="center" rowspan="1" colspan="1">1 year</th><th align="center" rowspan="1" colspan="1">2 years</th><th align="center" rowspan="1" colspan="1">3 and 4 years</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value<sup><xref ref-type="table-fn" rid="TFN3">a</xref></sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Overall survival</td><td align="center" rowspan="1" colspan="1">62.8%<break/>(55.3-70.4)</td><td align="center" rowspan="1" colspan="1">36.2%<break/>(28.7-43.8)</td><td align="center" rowspan="1" colspan="1">32.1%<break/>(24.7-39.5)</td><td align="center" rowspan="1" colspan="1">29.9%<break/>(22.6-37.2)</td><td align="center" rowspan="1" colspan="1">27.6%<break/>(20.2-35.0)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Preoperative</bold>
</td></tr><tr><td align="left" rowspan="2" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">&#x0003c;60 years old</td><td align="center" rowspan="1" colspan="1">78.6%<break/>(69.0-88.2)</td><td align="center" rowspan="1" colspan="1">46.5%<break/>(34.7-58.3)</td><td align="center" rowspan="1" colspan="1">43.2%<break/>(31.4-55.0)</td><td align="center" rowspan="1" colspan="1">41.5%<break/>(29.8-53.3)</td><td align="center" rowspan="1" colspan="1">38.8%<break/>(26.6-51.0)</td><td align="center" rowspan="2" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;60 years old</td><td align="center" rowspan="1" colspan="1">50.0%<break/>(39.4-60.6)</td><td align="center" rowspan="1" colspan="1">27.9%<break/>(18.4-37.4)</td><td align="center" rowspan="1" colspan="1">23.3%<break/>(14.3-32.2)</td><td align="center" rowspan="1" colspan="1">20.9%<break/>(12.3-29.5)</td><td align="center" rowspan="1" colspan="1">19.0%<break/>(10.4-27.6)</td></tr><tr><td align="left" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">67.7%<break/>(56.3-79.1)</td><td align="center" rowspan="1" colspan="1">30.7%<break/>(19.5-41.9)</td><td align="center" rowspan="1" colspan="1">29%<break/>(17.9-40.1)</td><td align="center" rowspan="1" colspan="1">27.3%<break/>(16.3-38.2)</td><td align="center" rowspan="1" colspan="1">27.3%<break/>(16.3-38.2)</td><td align="center" rowspan="2" colspan="1">0.933</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">59.4%<break/>(49.3-69.5)</td><td align="center" rowspan="1" colspan="1">40.3%<break/>(30.2-50.5)</td><td align="center" rowspan="1" colspan="1">34.4%<break/>(24.5-44.3)</td><td align="center" rowspan="1" colspan="1">31.7%<break/>(21.9-41.5)</td><td align="center" rowspan="1" colspan="1">27.6%<break/>(17.5-37.7)</td></tr><tr><td align="left" rowspan="4" colspan="1">Comorbidities</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus </td><td align="center" rowspan="1" colspan="1">72.8%<break/>(61.8-83.9)</td><td align="center" rowspan="1" colspan="1">38.8%<break/>(26.6-50.9)</td><td align="center" rowspan="1" colspan="1">28.2%<break/>(16.8-39.6)</td><td align="center" rowspan="1" colspan="1">28.2%<break/>(16.8-39.6)</td><td align="center" rowspan="1" colspan="1">25.1%<break/>(13.4-36.7)</td><td align="center" rowspan="1" colspan="1">0.642</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">64.4%<break/>(56.3-72.6)</td><td align="center" rowspan="1" colspan="1">39.1%<break/>(30.7-47.4)</td><td align="center" rowspan="1" colspan="1">34.1%<break/>(25.9-42.3)</td><td align="center" rowspan="1" colspan="1">31.5%<break/>(23.4-39.6)</td><td align="center" rowspan="1" colspan="1">28.5%<break/>(20.2-36.8)</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">65.7%<break/>(56.2-75.2)</td><td align="center" rowspan="1" colspan="1">40.1%<break/>(30.3-50.0)</td><td align="center" rowspan="1" colspan="1">34.4%<break/>(24.7-44.1)</td><td align="center" rowspan="1" colspan="1">31.9%<break/>(22.3-41.5)</td><td align="center" rowspan="1" colspan="1">27.8%<break/>(17.8-37.7)</td><td align="center" rowspan="1" colspan="1">0.373</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior AMI</td><td align="center" rowspan="1" colspan="1">73.4%<break/>(55.2-91.7)</td><td align="center" rowspan="1" colspan="1">45.4%<break/>(24.4-66.4)</td><td align="center" rowspan="1" colspan="1">40.4%<break/>(19.5-61.3)</td><td align="center" rowspan="1" colspan="1">35.3%<break/>(14.9-55.8)</td><td align="center" rowspan="1" colspan="1">23.6%<break/>(0.3-46.8)</td><td align="center" rowspan="1" colspan="1">0.477</td></tr><tr><td align="left" rowspan="3" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x0003c;25</td><td align="center" rowspan="1" colspan="1">65.5%<break/>(52.9-78.0)</td><td align="center" rowspan="1" colspan="1">40.0%<break/>(27.1-52.9)</td><td align="center" rowspan="1" colspan="1">35.8%<break/>(23.0-48.6)</td><td align="center" rowspan="1" colspan="1">33.4%<break/>(20.6-46.2)</td><td align="center" rowspan="1" colspan="1">30.6%<break/>(17.8-43.5)</td><td align="center" rowspan="3" colspan="1">0.834</td></tr><tr><td align="left" rowspan="1" colspan="1">25-29.9</td><td align="center" rowspan="1" colspan="1">64.7%<break/>(51.1-78.2)</td><td align="center" rowspan="1" colspan="1">34.4%<break/>(20.7-48.0)</td><td align="center" rowspan="1" colspan="1">32.1%<break/>(18.6-45.5)</td><td align="center" rowspan="1" colspan="1">29.8%<break/>(16.6-43.0)</td><td align="center" rowspan="1" colspan="1">29.8%<break/>(16.6-43.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02265;30</td><td align="center" rowspan="1" colspan="1">62.2%<break/>(48.1-76.4)</td><td align="center" rowspan="1" colspan="1">35.6%<break/>(21.6-49.5)</td><td align="center" rowspan="1" colspan="1">28.9%<break/>(15.6-42.1)</td><td align="center" rowspan="1" colspan="1">26.7%<break/>(13.7-39.6)</td><td align="center" rowspan="1" colspan="1">21.3%<break/>(7.4-35.3)</td></tr><tr><td align="left" rowspan="5" colspan="1">GFR</td><td align="left" rowspan="1" colspan="1">GFR I &#x02013; Normal</td><td align="center" rowspan="1" colspan="1">63.7%<break/>(40.4-87.0)</td><td align="center" rowspan="1" colspan="1">25.5%<break/>(4.0-47.0)</td><td align="center" rowspan="1" colspan="1">19.1%<break/>(0.0-38.5)</td><td align="center" rowspan="1" colspan="1">19.1%<break/>(0.0-38.5)</td><td align="center" rowspan="1" colspan="1">19.1%<break/>(0.0-38.5)</td><td align="center" rowspan="5" colspan="1">0.017</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR II - Mild</td><td align="center" rowspan="1" colspan="1">53.3%<break/>(38.8-67.9)</td><td align="center" rowspan="1" colspan="1">31.1%<break/>(17.6-44.6)</td><td align="center" rowspan="1" colspan="1">28.7%<break/>(15.4-42.0)</td><td align="center" rowspan="1" colspan="1">26.3%<break/>(13.4-39.3)</td><td align="center" rowspan="1" colspan="1">26.3%<break/>(13.4-39.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR III - Moderate</td><td align="center" rowspan="1" colspan="1">60.0%<break/>(46.4-73.6)</td><td align="center" rowspan="1" colspan="1">34.0%<break/>(20.9-47.1)</td><td align="center" rowspan="1" colspan="1">28.0%<break/>(15.6-40.4)</td><td align="center" rowspan="1" colspan="1">25.8%<break/>(13.7-38.0)</td><td align="center" rowspan="1" colspan="1">23.0%<break/>(10.9-35.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR IV &#x02013; Severe<sup><xref ref-type="table-fn" rid="TFN4">b</xref></sup></td><td align="center" rowspan="1" colspan="1">50.0%<break/>(15.4-84.6)</td><td align="center" rowspan="1" colspan="1">12.5%<break/>(0.0-35.4)</td><td align="center" rowspan="1" colspan="1">12.5%<break/>(0.0-35.4)</td><td align="center" rowspan="1" colspan="1">12.5%<break/>(0.0-35.4)</td><td align="center" rowspan="1" colspan="1">12.5%<break/>(0.0-35.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR V - Kidney failure<sup><xref ref-type="table-fn" rid="TFN4">b</xref></sup></td><td align="center" rowspan="1" colspan="1">81.8%<break/>(68.7-95.0)</td><td align="center" rowspan="1" colspan="1">59.8%<break/>(42.8-76.7)</td><td align="center" rowspan="1" colspan="1">56.1%<break/>(38.7-73.4)</td><td align="center" rowspan="1" colspan="1">52.3%<break/>(34.6-70.0)</td><td align="center" rowspan="1" colspan="1">46.5%<break/>(27.4-65.6)</td></tr><tr><td align="left" colspan="8" rowspan="1">Intraoperative</td></tr><tr><td align="left" rowspan="4" colspan="1">Type of surgery</td><td align="left" rowspan="1" colspan="1">Myocardial revascularization</td><td align="center" rowspan="1" colspan="1">71.4%<break/>(59.6-83.3)</td><td align="center" rowspan="1" colspan="1">44.6%<break/>(31.5-57.6)</td><td align="center" rowspan="1" colspan="1">35.3%<break/>(22.7-47.9)</td><td align="center" rowspan="1" colspan="1">33.4%<break/>(21.0-45.9)</td><td align="center" rowspan="1" colspan="1">27.0%<break/>(14.1-39.9)</td><td align="center" rowspan="4" colspan="1">0.171</td></tr><tr><td align="left" rowspan="1" colspan="1">Valve</td><td align="center" rowspan="1" colspan="1">57.2%<break/>(46.2-68.3)</td><td align="center" rowspan="1" colspan="1">34.6%<break/>(23.8-45.3)</td><td align="center" rowspan="1" colspan="1">33.1%<break/>(22.4-43.7)</td><td align="center" rowspan="1" colspan="1">31.6%<break/>(21.0-42.1)</td><td align="center" rowspan="1" colspan="1">31.6%<break/>(21.0-42.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Correction aorta aneurysm </td><td align="center" rowspan="1" colspan="1">100.0%<break/>(29.0-100)</td><td align="center" rowspan="1" colspan="1">66.7%<break/>(13.3-100.0)</td><td align="center" rowspan="1" colspan="1">66.7%<break/>(13.3-100.0)</td><td align="center" rowspan="1" colspan="1">33.3%<break/>(0-86.7)</td><td align="center" rowspan="1" colspan="1">33.3%<break/>(0-86.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Combined</td><td align="center" rowspan="1" colspan="1">55.0%<break/>(33.2-76.8)</td><td align="center" rowspan="1" colspan="1">15.0%<break/>(0.0-30.6)</td><td align="center" rowspan="1" colspan="1">15.0%<break/>(0.0-30.6)</td><td align="center" rowspan="1" colspan="1">15.0%<break/>(0.0-30.6)</td><td align="center" rowspan="1" colspan="1">15.0%<break/>(0.0-30.6)</td></tr><tr><td align="left" rowspan="3" colspan="1">CPB time</td><td align="left" rowspan="1" colspan="1">&#x0003c; 120min</td><td align="center" rowspan="1" colspan="1">63.4%<break/>(53.0-73.8)</td><td align="center" rowspan="1" colspan="1">46.3%<break/>(35.3-57.1)</td><td align="center" rowspan="1" colspan="1">41.1%<break/>(30.4-51.8)</td><td align="center" rowspan="1" colspan="1">37.0%<break/>(26.3-47.6)</td><td align="center" rowspan="1" colspan="1">34.9%<break/>(24.1-45.7)</td><td align="center" rowspan="2" colspan="1">0.054</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02265; 120min</td><td align="center" rowspan="1" colspan="1">62.1%<break/>(51.0-73.2)</td><td align="center" rowspan="1" colspan="1">24.7%<break/>(14.8-34.7)</td><td align="center" rowspan="1" colspan="1">21.8%<break/>(12.2-31.4)</td><td align="center" rowspan="1" colspan="1">21.8%<break/>(12.2-31.4)</td><td align="center" rowspan="1" colspan="1">19.4%<break/>(9.8-29.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vasoactive drugs</td><td align="center" rowspan="1" colspan="1">62.7%<break/>(54.5-70.9)</td><td align="center" rowspan="1" colspan="1">34.7%<break/>(26.6-42.8)</td><td align="center" rowspan="1" colspan="1">31.4%<break/>(23.5-39.4)</td><td align="center" rowspan="1" colspan="1">29.8%<break/>(21.9-37.6)</td><td align="center" rowspan="1" colspan="1">26.8%<break/>(18.8-34.9)</td><td align="center" rowspan="1" colspan="1">0.519</td></tr><tr><td align="left" colspan="8" rowspan="1">Postoperative</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasoactive drugs</td><td align="center" rowspan="1" colspan="1">63.4%<break/>(55.6-71.1)</td><td align="center" rowspan="1" colspan="1">35.7%<break/>(28.0-43.4)</td><td align="center" rowspan="1" colspan="1">31.3%<break/>(23.8-38.8)</td><td align="center" rowspan="1" colspan="1">29.0%<break/>(21.6-36.4)</td><td align="center" rowspan="1" colspan="1">26.6%<break/>(19.2-34.1)</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Blood transfusion</td><td align="center" rowspan="1" colspan="1">57.6%<break/>(47.0-68.3)</td><td align="center" rowspan="1" colspan="1">30.6%<break/>(20.7-40.6)</td><td align="center" rowspan="1" colspan="1">29.4%<break/>(19.5-39.3)</td><td align="center" rowspan="1" colspan="1">25.6%<break/>(16.0-35.1)</td><td align="center" rowspan="1" colspan="1">23.8%<break/>(14.4-33.3)</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Low cardiac output</td><td align="center" rowspan="1" colspan="1">61.1%<break/>(38.6-83.6)</td><td align="center" rowspan="1" colspan="1">24.4%<break/>(3.8-45.1)</td><td align="center" rowspan="1" colspan="1">24.4%<break/>(3.8-45.1)</td><td align="center" rowspan="1" colspan="1">24.4%<break/>(3.8-45.1)</td><td align="center" rowspan="1" colspan="1">24.4%<break/>(3.8-45.1)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="3" colspan="1">No. of complications</td><td align="left" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">88.5%<break/>(73.6-100.0)</td><td align="center" rowspan="1" colspan="1">82.6%<break/>(64.8-100.0)</td><td align="center" rowspan="1" colspan="1">62.4%<break/>(38.3-86.5)</td><td align="center" rowspan="1" colspan="1">62.4%<break/>(38.3-86.5)</td><td align="center" rowspan="1" colspan="1">41.6%<break/>(4.6-78.6)</td><td align="center" rowspan="3" colspan="1">0.0003</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">71.4%<break/>(56.5-86.4)</td><td align="center" rowspan="1" colspan="1">51.4%<break/>(34.9-68.0)</td><td align="center" rowspan="1" colspan="1">48.2%<break/>(31.5-64.9)</td><td align="center" rowspan="1" colspan="1">41.8%<break/>(25.1-58.5)</td><td align="center" rowspan="1" colspan="1">41.8%<break/>(25.1-58.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">2 or more</td><td align="center" rowspan="1" colspan="1">55.6%<break/>(46.0-65.2)</td><td align="center" rowspan="1" colspan="1">23.4%<break/>(15.2-31.6)</td><td align="center" rowspan="1" colspan="1">21.5%<break/>(13.5-29.4)</td><td align="center" rowspan="1" colspan="1">20.5%<break/>(12.7-28.3)</td><td align="center" rowspan="1" colspan="1">15.3%<break/>(6.2-24.4)</td></tr><tr><td align="left" rowspan="4" colspan="1">Length of stay in ICU (Days)</td><td align="left" rowspan="1" colspan="1">1-3</td><td align="center" rowspan="1" colspan="1">66.7%<break/>(51.3-82.1)</td><td align="center" rowspan="1" colspan="1">44.4%<break/>(28.2-60.7)</td><td align="center" rowspan="1" colspan="1">41.0%<break/>(24.7-57.3)</td><td align="center" rowspan="1" colspan="1">34.2%<break/>(18.1-50.3)</td><td align="center" rowspan="1" colspan="1">29.3%<break/>(12.9-45.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">4-10</td><td align="center" rowspan="1" colspan="1">63.2%<break/>(47.8-78.5)</td><td align="center" rowspan="1" colspan="1">44.7%<break/>(28.9-60.5)</td><td align="center" rowspan="1" colspan="1">36.8%<break/>(21.5-52.2)</td><td align="center" rowspan="1" colspan="1">36.8%<break/>(21.5-52.2)</td><td align="center" rowspan="1" colspan="1">36.8%<break/>(21.5-52.2)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">11-30</td><td align="center" rowspan="1" colspan="1">34.0%<break/>(20.5-47.4)</td><td align="center" rowspan="1" colspan="1">21.2%<break/>(9.6-32.9)</td><td align="center" rowspan="1" colspan="1">21.2%<break/>(9.6-32.9)</td><td align="center" rowspan="1" colspan="1">21.2%<break/>(9.6-32.9)</td><td align="center" rowspan="1" colspan="1">21.2%<break/>(9.6-32.9)</td><td align="center" rowspan="1" colspan="1">0.088</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;30</td><td align="center" rowspan="1" colspan="1">100.0%<break/>(88.4-100.0)</td><td align="center" rowspan="1" colspan="1">33.0%<break/>(16.0-50.0)</td><td align="center" rowspan="1" colspan="1">29.3%<break/>(12.8-45.9)</td><td align="center" rowspan="1" colspan="1">25.1%<break/>(9.1-41.2)</td><td align="center" rowspan="1" colspan="1">20.1%<break/>(4.5-35.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>AMI=acute myocardial infarction; BMI=body mass index; GFR=glomerular
filtration rate</p></fn><fn id="TFN3"><label>a</label><p>Long-rank test;</p></fn><fn id="TFN4"><label>b</label><p><italic>P</italic>&#x0003c;0.05 pairwise with Bonferroni correct. Value are n
(%)</p></fn></table-wrap-foot></table-wrap><p>
<xref rid="t2" ref-type="table">Table 2</xref> shows associations between the pre,
intra and postoperative variables and survival rates at different points in time.
Overall survival for the first 30 days postoperative was 62.8%. Association between
survival and preoperative variables revealed age with
<italic>P</italic>-value=0.001; survival rate was lower for patients older than 60
years of age and remained low over time among the patients in this age range.</p><p>GFR presented <italic>P</italic>-value=0.017, while patients with GFR V (kidney
failure) presented better survival results (81.8%) within 30 days and over time,
when compared to the survival of the remaining patients at different stages of
kidney disease (GFR I, GFR II, GFR III, GFR IV).</p><p>CPB duration was not statistically significant for survival, while the presence of
complications was significant (<italic>P</italic>-value=0.0003) in the association
between survival and postoperative variables.</p><p>Cox regression was performed based on the multivariate analysis and the effect of the
covariates age, GFR, CPB time, postoperative complications, length of stay in ICU
and survival time was estimated. Data are presented in <xref rid="t3" ref-type="table">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Analysis of survival among the variables age, GFR, CPB time, complications
and length of stay in ICU (Days). S&#x000e3;o Paulo, Brazil 2014.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="2" colspan="1">HR</th><th align="center" colspan="2" rowspan="1">CI (95%) of HR</th><th align="center" rowspan="2" colspan="1"><italic>P</italic>-value</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower Lim</th><th align="center" rowspan="1" colspan="1">Upper Lim</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">1.039</td><td align="center" rowspan="1" colspan="1">1.019</td><td align="center" rowspan="1" colspan="1">1.059</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR I</td><td align="center" rowspan="1" colspan="1">1.000</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR II</td><td align="center" rowspan="1" colspan="1">0.879</td><td align="center" rowspan="1" colspan="1">0.421</td><td align="center" rowspan="1" colspan="1">1.835</td><td align="center" rowspan="1" colspan="1">0.7323</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR III</td><td align="center" rowspan="1" colspan="1">0.851</td><td align="center" rowspan="1" colspan="1">0.393</td><td align="center" rowspan="1" colspan="1">1.839</td><td align="center" rowspan="1" colspan="1">0.6817</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR IV</td><td align="center" rowspan="1" colspan="1">1.163</td><td align="center" rowspan="1" colspan="1">0.404</td><td align="center" rowspan="1" colspan="1">3.344</td><td align="center" rowspan="1" colspan="1">0.7785</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR V</td><td align="center" rowspan="1" colspan="1">0.614</td><td align="center" rowspan="1" colspan="1">0.252</td><td align="center" rowspan="1" colspan="1">1.496</td><td align="center" rowspan="1" colspan="1">0.2833</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">1.418</td><td align="center" rowspan="1" colspan="1">0.924</td><td align="center" rowspan="1" colspan="1">2.175</td><td align="center" rowspan="1" colspan="1">0.1095</td></tr><tr><td align="left" rowspan="1" colspan="1">Complications</td><td align="center" rowspan="1" colspan="1">2.076</td><td align="center" rowspan="1" colspan="1">1.189</td><td align="center" rowspan="1" colspan="1">3.623</td><td align="center" rowspan="1" colspan="1">0.0101</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 1-3</td><td align="center" rowspan="1" colspan="1">1.000</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 4-10</td><td align="center" rowspan="1" colspan="1">0.736</td><td align="center" rowspan="1" colspan="1">0.400</td><td align="center" rowspan="1" colspan="1">1.356</td><td align="center" rowspan="1" colspan="1">0.3270</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 11-30</td><td align="center" rowspan="1" colspan="1">0.871</td><td align="center" rowspan="1" colspan="1">0.492</td><td align="center" rowspan="1" colspan="1">1.540</td><td align="center" rowspan="1" colspan="1">0.6356</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU &#x0003e;30</td><td align="center" rowspan="1" colspan="1">0.381</td><td align="center" rowspan="1" colspan="1">0.199</td><td align="center" rowspan="1" colspan="1">0.733</td><td align="center" rowspan="1" colspan="1">0.0038</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>CPB=cardiopulmonary bypass; GFR=glomerular filtration rate; HR=hazard
ratio; ICU=intensive care unit</p></fn></table-wrap-foot></table-wrap><p>The analysis of significant variables regarding survival showed that the older the
patient, the greater the risk of death; the risk increased 3.8% per year of life.
For CPB time &#x0003e;120 min the risk of death increased approximately 1.6 times when
compared to patients with CPB time &#x0003c; 120 min. For patients who presented two or
more complications, the risk of death increased approximately 2.3 times when
compared to patients with only one complication or no complications. For patients
who presented length of stay in ICU &#x0003e; 30 days, decreased 57% the risk of death
when compared to patients with length of stay in ICU &#x0003c; 3 days. Data are presented
in <xref rid="t4" ref-type="table">Table 4</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Analysis of survival after stepwise backward: variables age, CPB time,
complications and length of stay in ICU. S&#x000e3;o Paulo, Brazil 2014.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="2" colspan="1">HR</th><th align="center" colspan="2" rowspan="1">CI (95%) of HR</th><th align="center" rowspan="2" colspan="1"><italic>P</italic>-value</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower Lim</th><th align="center" rowspan="1" colspan="1">Upper Lim</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age </td><td align="center" rowspan="1" colspan="1">1.037</td><td align="center" rowspan="1" colspan="1">1.019</td><td align="center" rowspan="1" colspan="1">1.056</td><td align="center" rowspan="1" colspan="1">0.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">1.600</td><td align="center" rowspan="1" colspan="1">1.055</td><td align="center" rowspan="1" colspan="1">2.426</td><td align="center" rowspan="1" colspan="1">0.0268</td></tr><tr><td align="left" rowspan="1" colspan="1">Complications (&#x0003e;2)</td><td align="center" rowspan="1" colspan="1">2.300</td><td align="center" rowspan="1" colspan="1">1.399</td><td align="center" rowspan="1" colspan="1">3.780</td><td align="center" rowspan="1" colspan="1">0.0010</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 1-3</td><td align="center" rowspan="1" colspan="1">1.000</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 4-10</td><td align="center" rowspan="1" colspan="1">0.776</td><td align="center" rowspan="1" colspan="1">0.435</td><td align="center" rowspan="1" colspan="1">1.383</td><td align="center" rowspan="1" colspan="1">0.3909</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 11-30</td><td align="center" rowspan="1" colspan="1">0.879</td><td align="center" rowspan="1" colspan="1">0.502</td><td align="center" rowspan="1" colspan="1">1.540</td><td align="center" rowspan="1" colspan="1">0.6536</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay in ICU 11-30</td><td align="center" rowspan="1" colspan="1">0.426</td><td align="center" rowspan="1" colspan="1">0.227</td><td align="center" rowspan="1" colspan="1">0.8011</td><td align="center" rowspan="1" colspan="1">0.0081</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>CPB=cardiopulmonary bypass; HR=hazard ratio; ICU=intensive care unit</p></fn></table-wrap-foot></table-wrap><p>
<xref ref-type="fig" rid="f1">Figure 1</xref> represents the patients' overall
survival curve. The average time of survival in this study population was 1.5 years,
approximately 546 days.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Study patients' overall survival.</p></caption><graphic xlink:href="rbccv-33-03-0277-g01"/></fig>
</p><p>
<xref ref-type="fig" rid="f2">Figures 2</xref> and <xref ref-type="fig" rid="f3">3</xref> show survival in regard to the variables age and complications. The
dashed line in the first graphic represents only the survival of patients more than
the 60 years of age. The first and second dashed lines in the second graphic
represent the group with only one complication and two or more complications,
respectively.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Relationship between the survival and age of patients.</p></caption><graphic xlink:href="rbccv-33-03-0277-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Relationship between the survival of patients and number of
complications.</p></caption><graphic xlink:href="rbccv-33-03-0277-g03"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>AKI is a complication that frequently affects patients after cardiovascular surgery
and is associated with increased mortality<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>. The aim of this study is to analyze the
risk factors in patients who acquired postoperative AKI requiring dialysis after
cardiovascular surgery and analyze its survival rates.</p><p>The incidence and adverse outcomes associated with AKI in a population who underwent
cardiovascular surgery (myocardial revascularization and valve surgery) from 1999 to
2008 reports that the rates of AKI and AKI requiring dialysis after cardiovascular
surgery with extracorporeal circulation relates to age, gender, although
controversial<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>; type of surgery, heart failure, diabetes mellitus,
hypertension, lung disease, peripheral vascular disease, cerebrovascular disease,
obesity, sepsis, CPB time, and mechanical ventilation<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>.</p><p>Advanced age, as observed in this study, has been related to dialytic kidney failure
since the kidneys are prone to aging process<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>. One analysis with 145,911
patients<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup> aged 65 years old or older who had their aortic
valve replaced or repaired concomitantly with a myocardial revascularization,
between 1991 and 2007, reports an average survival of 13 years for patients aged
between 65 and 69 years old, 9 years for those between 70 and 79 and 6 years for
patients aged 80 years old or older. Although the type of surgery appears as an
important factor associated with decreased survival, it was not significant in this
study.</p><p>Interestingly, we did not notice in this series relation between BMI and EuroSCORE II
to decreased survival since they are well established to dialytic AKI in
cardiovascular patients<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>-</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. Other factors predicting AKI were identified in
patients who had undergone cardiovascular surgery and developed AKI that required
dialysis, such as having a preoperative severe status and preexisting kidney
disease<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup>.</p><p>Despite the reported survival rate in the first 30 days after surgery, it gradually
decreased in subsequent months. Similar evidence was identified in patients with
mild preoperative kidney failure, who presented a higher mortality rate in the long
term compared to patients whose preoperative kidney function was
normal<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>.</p><p>It is believed that mild and severe preoperative kidney failure leads to a greater
incidence of adverse events in the postoperative period<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>,</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. In this study,
preoperative kidney failure requiring dialysis was not related to higher mortality
rates. The patients with preoperative kidney failure (GFR V) presented greater
postoperative survival in the first 30 days and over time when compared to the
remaining patients, which may be associated with early dialysis therapy on the
post-operative period.</p><p>Patients undergoing dialysis in whom myocardial revascularization was performed
present higher mortality, approximately 7% to 10%, which is three times greater than
non-uremic patients<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. Long-term results show that the survival of
patients undergoing dialysis after coronary artery bypass graft (CABG) is decreased,
with mortality in 5 years estimated to be 48%<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>,</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>,</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>.</p><p>Patients who developed some degree of AKI, in addition to presenting high mortality
rates, also presented a high risk score, required more blood
transfusions<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>,</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>-</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>, presented a higher incidence of neurological
events, required mechanical ventilation for longer periods, and, consequently, were
hospitalized for longer periods with high rates of surgical wound
infection<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>.</p><p>Complications emerging in the preoperative phase of cardiovascular surgeries among
patients with AKI requiring dialysis significantly increase mortality
rates<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>,</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>. Among potential complications, pulmonary
atelectasis is reported as the main complication found in 54% to 92% of patients in
the postoperative period of cardiovascular surgery<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>. The presence of
complications identified in individuals who developed postoperative AKI that
requires dialysis after a cardiovascular surgery shows that these patients may
require mechanical ventilation for longer periods. On the other hand, mechanical
ventilation increases the risk of pulmonary infection, while AKI creates an altered
inflammatory environment that may cause atrial arrhythmias<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>.</p><p>One recent study revealed that AKI stage 1 and stages 2 or 3, according to AKIN
criteria, were associated with significant increase, from 31% to 98% of readmission
in five years, in addition to significant higher mortality risk, from 1.5 to 3.5
times, five years after surgery<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. Similar results were found in association with
increased intra-hospital mortality among patients who initiated dialysis later on
(&#x0003e;3 days) after cardiovascular surgery, in comparison to those who started
dialysis within three days after surgery<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>.</p><p>In this study, 140 out of the 157 patients presented some degree of preoperative
kidney disease and only 17 presented normal kidney function. All the patients,
however, required postoperative dialysis. Univariate analysis revealed significant
differences between the groups GFR IV (severe) and GFR V (renal failure) in the
pairwise analysis, with P=0.0109, though the GFR was not significant in the survival
of these patients, according to the Cox regression model. It is possible that the
fact that preoperative dialysis patients were introduced earlier to dialysis than
those who developed postoperative AKI and later required it explains the greater
survival rate among the first group of patients. Patients in a previous dialysis
program were not related to have long term mortality than new demanding dialysis
patients after cardiovascular surgery.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Data show an average survival of 546 days among dialytic AKI patients after
cardiovascular surgery, while factors such as age, and postoperative complications
were determinant regarding decreases in the survival of these patients.</p><p>The multidisciplinary staff in the intensive care unit must be aware of the profile
of these patients and understands how their clinical condition develops to refer
them to early dialysis in order to properly handle AKI and decrease irreversible
damage. The planning of interventions in the perioperative period is essential to
decreasing the emergence of AKI and avoiding complications, significantly
contributing to decreased mortality and improved survival of patients.</p><table-wrap id="t6" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">ABVS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception, acquisition, analysis and interpretation of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMRZC</td><td align="left" valign="top" rowspan="1" colspan="1">Contributions on interpretation of data,
drafting the work or revision it critically for important
intellectual content; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FPT</td><td align="left" valign="top" rowspan="1" colspan="1">Contribution to the conception and design
of the work, final approval of the version to be published and
agreement to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any part of
the work are appropriately investigated and resolved; final approval
of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Instituto Dante Pazzanese de Cardiologia,
S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>S</given-names></name><name><surname>Ross</surname><given-names>VC</given-names></name><name><surname>Zealley</surname><given-names>KA</given-names></name><name><surname>Millar</surname><given-names>F</given-names></name><name><surname>Isles</surname><given-names>C</given-names></name></person-group><article-title>Management of post-operative acute kidney injury</article-title><source>QJM</source><year>2017</year><volume>110</volume><issue>11</issue><fpage>695</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">27803367</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group><article-title>Global incidence and outcomes of adult patients with acute kidney
injury after cardiac surgery: a systematic review and
meta-analysis</article-title><source>J Cardiothorac Vasc Anesth</source><year>2016</year><volume>30</volume><issue>1</issue><fpage>82</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">26482484</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corredor</surname><given-names>C</given-names></name><name><surname>Thomson</surname><given-names>R</given-names></name><name><surname>Al-Subaie</surname><given-names>N</given-names></name></person-group><article-title>Long-term consequences of acute kidney injury after cardiac
surgery: a systematic review and meta-analysis</article-title><source>J Cardiothorac Vasc Anesth</source><year>2016</year><volume>30</volume><issue>1</issue><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">26482483</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorge-Monjas</surname><given-names>P</given-names></name><name><surname>Bustamante-Munguira</surname><given-names>J</given-names></name><name><surname>Lorenzo</surname><given-names>M</given-names></name><name><surname>Heredia-Rodr&#x000ed;quez</surname><given-names>M</given-names></name><name><surname>Fierro</surname><given-names>I</given-names></name><name><surname>G&#x000f3;mez-S&#x000e1;nchez</surname><given-names>E</given-names></name><etal/></person-group><article-title>Predicting cardiac surgery-associated acute kidney injury: The
CRATE score</article-title><source>J Crit Care</source><year>2016</year><volume>31</volume><issue>1</issue><fpage>130</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">26700607</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickering</surname><given-names>JW</given-names></name><name><surname>James</surname><given-names>MT</given-names></name><name><surname>Palmer</surname><given-names>SC</given-names></name></person-group><article-title>Acute kidney injury and prognosis after cardiopulmonary bypass: a
meta-analysis of cohort studies</article-title><source>Am J Kidney Dis</source><year>2015</year><volume>65</volume><issue>2</issue><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">25445101</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmistekawy</surname><given-names>E</given-names></name><name><surname>McDonald</surname><given-names>B</given-names></name><name><surname>Hudson</surname><given-names>C</given-names></name><name><surname>Ruel</surname><given-names>M</given-names></name><name><surname>Mesana</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><etal/></person-group><article-title>Clinical impact of mild acute kidney injury after cardiac
surgery</article-title><source>Ann Thorac Surg</source><year>2014</year><volume>98</volume><issue>3</issue><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">25086946</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Obesity: preventing and managing the global epidemic. Report of a World
Health Organization Consultation</source><comment>WHO Obesity Technical Report Series, n. 284</comment><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2000</year><fpage>256</fpage><lpage>256</lpage></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name><name><surname>Tsukamoto</surname><given-names>Y</given-names></name><name><surname>Levin</surname><given-names>A</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Rossert</surname><given-names>J</given-names></name><etal/></person-group><article-title>Definition and classification of chronic kidney disease: a
position statement from Kidney Disease: Improving Global Outcomes
(KDIGO)</article-title><source>Kidney Int</source><year>2005</year><volume>67</volume><issue>6</issue><fpage>2089</fpage><lpage>2100</lpage><pub-id pub-id-type="pmid">15882252</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CC</given-names></name><name><surname>Tan</surname><given-names>CS</given-names></name><name><surname>Chia</surname><given-names>CM</given-names></name><name><surname>Tan</surname><given-names>AK</given-names></name><name><surname>Choo</surname><given-names>JC</given-names></name><name><surname>Kaushik</surname><given-names>M</given-names></name><etal/></person-group><article-title>Long-term risk of progressive chronic kidney disease in patients
with severe acute kidney injury requiring dialysis after coronary artery
bypass surgery</article-title><source>Cardiorenal Med</source><year>2015</year><volume>5</volume><issue>3</issue><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">26195967</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Correa-Rotter</surname><given-names>R</given-names></name><name><surname>Hemmelgarn</surname><given-names>BR</given-names></name><name><surname>Jafar</surname><given-names>TH</given-names></name><name><surname>Heerspink</surname><given-names>HJ</given-names></name><name><surname>Mann</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Chronic kidney disease and cardiovascular risk: epidemiology,
mechanisms, and prevention</article-title><source>Lancet</source><year>2013</year><volume>382</volume><issue>9889</issue><fpage>339</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">23727170</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenihan</surname><given-names>CR</given-names></name><name><surname>Montez-Rath</surname><given-names>ME</given-names></name><name><surname>Mora Mangano</surname><given-names>CT</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name><name><surname>Winkelmayer</surname><given-names>WC</given-names></name></person-group><article-title>Trends in acute kidney injury, associated use of dialysis, and
mortality after cardiac surgery, 1999 to 2008</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>95</volume><issue>1</issue><fpage>20</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">23272825</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Cochran</surname><given-names>RP</given-names></name><name><surname>Dacey</surname><given-names>LJ</given-names></name><name><surname>Ross</surname><given-names>CS</given-names></name><name><surname>Kunzelman</surname><given-names>KS</given-names></name><name><surname>Dunton</surname><given-names>RF</given-names></name><etal/><collab>Northern New England Cardiovascular Disease Study Group</collab></person-group><article-title>Perioperative increases in serum creatinine are predictive of
increased 90-day mortality after coronary artery bypass graft
surgery</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>1 Suppl</issue><fpage>I409</fpage><lpage>I413</lpage><pub-id pub-id-type="pmid">16820609</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>JM</given-names></name><name><surname>Edwards</surname><given-names>FH</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Douglas</surname><given-names>PS</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><collab>Developing Evidence to Inform Decisions About Effectiveness-Aortic
Valve Replacement (DEcIDE AVR) research team</collab></person-group><article-title>Long-term survival after aortic valve replacement among high-risk
elderly patients in the United States: insights from the Society of Thoracic
Surgeons Adult Cardiac Surgery Database, 1991 to 2007</article-title><source>Circulation</source><year>2012</year><volume>126</volume><issue>13</issue><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="pmid">22907936</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelz</surname><given-names>RR</given-names></name><name><surname>Reinke</surname><given-names>CE</given-names></name><name><surname>Zubizarreta</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Saynisch</surname><given-names>P</given-names></name><name><surname>Even-Shoshan</surname><given-names>O</given-names></name><etal/></person-group><article-title>Acute kidney injury, renal function, and the elderly obese
surgical patient: a matched case-control study</article-title><source>Ann Surg</source><year>2013</year><volume>258</volume><issue>2</issue><fpage>359</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">23676533</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koochemeshki</surname><given-names>V</given-names></name><name><surname>Amestejani</surname><given-names>M</given-names></name><name><surname>Salmanzadeh</surname><given-names>HR</given-names></name><name><surname>Ardabili</surname><given-names>SS</given-names></name></person-group><article-title>The effect of obesity on mortality and morbidity after isolated
coronary artery bypass grafting surgery</article-title><source>Int Cardiovasc Res J</source><year>2012</year><volume>6</volume><issue>2</issue><fpage>46</fpage><lpage>50</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname><given-names>EB</given-names></name><name><surname>Bernardes Neto</surname><given-names>SCG</given-names></name><name><surname>Amorim</surname><given-names>FF</given-names></name><name><surname>Viscardi</surname><given-names>RC</given-names></name></person-group><article-title>Correla&#x000e7;&#x000e3;o do EuroSCORE com o surgimento de
les&#x000e3;o renal aguda p&#x000f3;s-operat&#x000f3;ria em cirurgia
card&#x000ed;aca</article-title><source>Rev Bras Ter Intensiva</source><year>2013</year><volume>25</volume><issue>3</issue><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">24213087</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>IN</given-names></name><name><surname>Moraes Neto</surname><given-names>FR</given-names></name><name><surname>Andrade</surname><given-names>TG</given-names></name></person-group><article-title>Use of EuroSCORE as a predictor of morbidity after cardiac
surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>1</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">24896157</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muralidhar</surname><given-names>K</given-names></name><name><surname>Bhagyashri</surname><given-names>K</given-names></name><name><surname>Guptha</surname><given-names>R</given-names></name><name><surname>Hegde</surname><given-names>N</given-names></name><name><surname>Ahmed</surname><given-names>I</given-names></name><name><surname>Vincent</surname><given-names>L</given-names></name></person-group><article-title>Determinants of renal replacement therapy after adult cardiac
surgery</article-title><source>Asian Cardiovasc Thorac Ann</source><year>2013</year><volume>21</volume><issue>5</issue><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">24570554</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>MN</given-names></name><name><surname>Nakazone</surname><given-names>MA</given-names></name><name><surname>Maia</surname><given-names>LN</given-names></name></person-group><article-title>Acute kidney injury based on KDIGO (Kidney Disease Improving
Global Outcomes) criteria in patients with elevated baseline serum
creatinine undergoing cardiac surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>3</issue><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">25372901</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neal</surname><given-names>JB</given-names></name><name><surname>Shaw</surname><given-names>AD</given-names></name><name><surname>Billings</surname><given-names>FT 4th</given-names></name></person-group><article-title>Acute kidney injury following cardiac surgery: current
understanding and future directions</article-title><source>Crit Care</source><year>2016</year><volume>20</volume><issue>1</issue><fpage>187</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">27373799</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>UA</given-names></name><name><surname>Coca</surname><given-names>SG</given-names></name><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Koyner</surname><given-names>JL</given-names></name><name><surname>Garg</surname><given-names>AX</given-names></name><name><surname>Passik</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Blood transfusions are associated with urinary biomarkers of
kidney injury in cardiac surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>148</volume><issue>2</issue><fpage>726</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">24820190</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>CI</given-names></name><name><surname>Frase</surname><given-names>JF</given-names></name><name><surname>Coombes</surname><given-names>JS</given-names></name><name><surname>Fung</surname><given-names>YL</given-names></name></person-group><article-title>Oxidative stress during extracorporeal
circulation</article-title><source>Eur J Cardiothorac Surg</source><year>2014</year><volume>46</volume><issue>6</issue><fpage>937</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">24482384</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Grocott</surname><given-names>HP</given-names></name><name><surname>Hall</surname><given-names>R</given-names></name><name><surname>Jessen</surname><given-names>ME</given-names></name><name><surname>Kruger</surname><given-names>C</given-names></name><name><surname>Lerner</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Interrelationship of preoperative anemia, intraoperative anemia,
and red blood cell transfusion as potentially modifiable risk factors for
acute kidney injury in cardiac surgery: a historical multicentre cohort
study</article-title><source>Can J Anaesth</source><year>2015</year><volume>62</volume><issue>4</issue><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">25537735</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szelkowski</surname><given-names>LA</given-names></name><name><surname>Puri</surname><given-names>NK</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Massimiano</surname><given-names>PS</given-names></name></person-group><article-title>Current trends in preoperative, intraoperative, and postoperative
care of the adult cardiac surgery patient</article-title><source>Curr Probl Surg</source><year>2015</year><volume>52</volume><issue>1</issue><fpage>531</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">25524515</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Hisey</surname><given-names>WM</given-names></name><name><surname>Marshall</surname><given-names>EJ</given-names></name><name><surname>Likosky</surname><given-names>DS</given-names></name><name><surname>Nichols</surname><given-names>EL</given-names></name><name><surname>Everett</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Acute kidney injury severity and long-term readmission and
mortality after cardiac surgery</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>102</volume><issue>5</issue><fpage>1482</fpage><lpage>1489</lpage><pub-id pub-id-type="pmid">27319985</pub-id></element-citation></ref></ref-list></back></article>